Clinical Trials Insight: 700020282
Phase of Trial: Phase I
Latest Information Update: 30 May 2009
At a glance
- Drugs PX 12 (Primary)
- Indications Gastric cancer; Intestinal cancer
- Focus Therapeutic Use
- Sponsors Oncothyreon
- 30 May 2009 Final results have been presented at American Society of Clinical Oncology (ASCO) Annual Meeting, according to an Oncothyreon media release.
- 30 May 2009 Status changed from active, no longer recruiting to completed. Final results have been presented.
- 10 Jan 2007 New trial record.